Lung Disease News and Research

RSS

Photon-counting CT protocol shows promise for lung imaging

New CT technology allows for a comprehensive, simultaneous evaluation of lung structure and function, something not possible with standard CT, according to a study published in Radiology, a journal of the Radiological Society of North America.

11 Jul 2023

The causative role of age-associated pre-existing senescent cells on COVID-19 severity

Researchers investigated the role of senescent cells in the context of SARS-CoV-2 infection.

10 Jul 2023

Pulse oximetry: A 50-year-old device gets an upgrade

A portable device used to detect blood oxygen levels revolutionized the medical field 50 years ago and is now receiving essential updates

7 Jul 2023

Triple combination therapy shows promise in long-term treatment of cystic fibrosis

The mucus in the airways is not as sticky, inflammation in the lungs significantly reduced: Triple combination therapy can achieve these positive, lasting effects in patients with cystic fibrosis (CF).

7 Jul 2023

UC researchers discover treatment for a rare cancer-like lung disease in women

A treatment for a rare cancer-like lung disease found in women of childbearing age may have been discovered by University of Cincinnati researchers.

15 Jun 2023

Researchers create first integrated single-cell atlas of the human lung

The largest and most comprehensive cell map of the human lung is announced in Nature Medicine today (8 June). Revealing the great diversity of cell types in the lung and key differences between health and disease, the Human Lung Cell Atlas will be a valuable resource for lung researchers.

10 Jun 2023

Experimental drug may slow the progression of atherosclerosis

An experimental drug already tested as a potential treatment for cancer, lung disease, and Alzheimer's disease may slow the progression of atherosclerosis that leads to heart disease, a new study shows.

8 Jun 2023

Two studies seek to understand the drivers of chronic and progressive phase of COVID-19

Early studies of COVID-19 focused on the acute phase of the disease. However, attention has now turned to the long-term consequences of the disease, which are also significant causes of morbidity and mortality.

6 Jun 2023

Trends in the prevalence of individual health risk factors: how has the mortality risk changed over time?

Researchers explored the prevalence of health risk factors and their correlation with all-cause mortality.

6 Jun 2023

University of Louisville researchers receive $5.8 million to prevent immune system dysregulation

Researchers at the University of Louisville have received $5.8 million in two grants from the National Institutes of Health to expand their work to better understand and prevent immune system dysregulation responsible for acute respiratory distress, the condition responsible for serious illness and death in some COVID-19 patients.

2 Jun 2023

Rheumatic and musculoskeletal diseases increase the risk of lethal comorbidities

Rheumatic and musculoskeletal diseases (RMDs) include over 200 diseases that affect over 120 million Europeans of all ages.

1 Jun 2023

Study measures the annual prevalence of nontuberculous mycobacterial lung disease in Ontario, Canada

Researchers determined the prevalence of nontuberculous mycobacterial pulmonary disease (NTM-PD) in 2020.

1 Jun 2023

Risk of long COVID in the United Kingdom and Hong Kong cohorts

Study evaluates the risk of post-acute sequelae of COVID-19 in the United Kingdom (UK) and Hong Kong (HK).

30 May 2023

Novel regulators of COPD determined by epigenetic profiling

Impaired function of lung fibroblast is considered causative for symptoms of the incurable lung disease COPD (Chronic Obstructive Pulmonary Disease).

25 May 2023

University Hospitals Birmingham partners with Qureight for lung disease research

University Hospitals Birmingham (UHB) has partnered with medical technology company, Qureight, to build more diverse artificial intelligence (AI) models that accurately reflect communities; a world-first lung disease research partnership.

22 May 2023

Researchers identify a major stem cell variant in lungs of patients with idiopathic pulmonary fibrosis

A pair of internationally renowned stem cell cloning experts at the University of Houston is reporting their findings of variant cells in the lungs of patients with Idiopathic Pulmonary Fibrosis (IPF) which likely represent key targets in any future therapy for the condition.

17 May 2023

New technology can deliver gene therapy directly to the lung

Scientists at UMass Chan Medical School have developed a technology to deliver gene therapy directly to lung tissue through intranasal administration, a development that could potentially create a new class of treatments for lung disease.

2 May 2023

Understanding post-COVID interstitial lung disease: Causes, treatment options

After being hospitalized for three months with COVID-19 and double pneumonia in 2020, Houston police officer Hito Bazan awoke one morning to discover that he couldn't talk, eat, walk, or most importantly, breathe. Bazan was diagnosed with interstitial lung disease (ILD) known as pulmonary fibrosis (PF).

27 Apr 2023

PFF Walk series launched to raise funds and awareness for pulmonary fibrosis and interstitial lung disease

The Pulmonary Fibrosis Foundation (PFF) today announced the launch of its annual PFF Walk series, a nationwide effort to raise funds and awareness for pulmonary fibrosis (PF) and interstitial lung disease (ILD).

25 Apr 2023

RSV infection in the first year of life associated with increased risk of childhood asthma

Severe respiratory syncytial virus (RSV) infection has long been associated with the onset of childhood wheezing diseases, but the relationship between RSV infection during infancy and the development of childhood asthma has remained unclear.

24 Apr 2023